[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,945,172
  • Shares Outstanding, K 419,228
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,435 M
  • EBITDA $ 3,922 M
  • 60-Month Beta 0.75
  • Price/Sales 3.39
  • Price/Cash Flow 10.12
  • Price/Book 9.96

Options Overview Details

View History
  • Implied Volatility 51.57% (+0.09%)
  • Historical Volatility 29.98%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 51.57% on 07/21/26
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 31) 7.57 (10.07%)
  • Put/Call Vol Ratio 1.25
  • Today's Volume 3,270
  • Volume Avg (30-Day) 4,741
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 133,260
  • Open Int (30-Day) 145,517
  • Expected Range 67.54 to 82.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.85
  • Number of Estimates 8
  • High Estimate $1.89
  • Low Estimate $1.77
  • Prior Year $1.76
  • Growth Rate Est. (year over year) +5.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.47 +5.43%
on 06/30/26
79.90 -5.70%
on 06/25/26
-3.36 (-4.27%)
since 06/18/26
3-Month
71.47 +5.43%
on 06/30/26
119.91 -37.16%
on 04/22/26
-42.83 (-36.24%)
since 04/21/26
52-Week
71.47 +5.43%
on 06/30/26
160.48 -53.05%
on 08/20/25
-72.02 (-48.87%)
since 07/21/25

Most Recent Stories

More News
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , July 21, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ZTS : 75.35 (-1.12%)
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

NEW YORK , July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).

ZTS : 75.35 (-1.12%)
ZTS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ZTS Investors with Losses to Contact the Firm

Did you buy ZTS securities   between January 14, 2025, and May 6, 2026?

ZTS : 75.35 (-1.12%)
ZTS Deadline: ZTS Investors with Loses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK , July 20, 2026 /PRNewswire/ --

ZTS : 75.35 (-1.12%)
ZTS Deadline: Rosen Law Firm Urges Zoetis Inc. (NYSE: ZTS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14,...

ZTS : 75.35 (-1.12%)
Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS

LOS ANGELES , July 20, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS ) for violations of...

ZTS : 75.35 (-1.12%)
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , July 20, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or...

ZTS : 75.35 (-1.12%)
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZOETIS INC. (ZTS), CLICK HERE   BEFORE JULY 27, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD ...

ZTS : 75.35 (-1.12%)
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. Lawsuit - ZTS

Wall Street's Reassessment of Zoetis Accelerated as Analyst Downgrades Followed Each Corrective Disclosure, Reflecting Growing Skepticism That Management's Companion Animal Growth Narrative Was Built on...

ZTS : 75.35 (-1.12%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS

NEW YORK , July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS).   Such investors are...

ZTS : 75.35 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 78.77
2nd Resistance Point 77.63
1st Resistance Point 76.92
Last Price 75.35
1st Support Level 75.07
2nd Support Level 73.93
3rd Support Level 73.22

See More

52-Week High 160.48
Fibonacci 61.8% 126.48
Fibonacci 50% 115.97
Fibonacci 38.2% 105.47
Last Price 75.35
52-Week Low 71.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.